Sector ratings Caplin Point Laboratories Limited NSE India S.E.
Stocks
CAPLIPOINT
INE475E01026
Pharmaceuticals
|
Market Closed -
NSE India S.E.
15:05:07 10/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 2,795.40 INR | +2.66% |
|
-1.74% | +52.08% |
| 08-14 | Caplin Point Laboratories Limited, Q1 2027 Earnings Call, Aug 12, 2026 | |
| 08-12 | Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 47.02B | B | ||||||||
| 39.94B | A | ||||||||
| 11.82B | BB | ||||||||
| 11.57B | A | ||||||||
| 9.18B | - | ||||||||
| 7.32B | A | ||||||||
| 7.22B | BB | ||||||||
| 7.2B | AA | ||||||||
| 5.2B | - | BB | - | - | - | ||||
| 4.64B | BB | ||||||||
| 4.37B | A | ||||||||
| 3.84B | - | BB | - | - | - | - | - | ||
| 3.79B | A | ||||||||
| 2.88B | - | CCC | - | - | - | - | - | ||
| 2.85B | B | ||||||||
| 2.71B | - | B | - | - | - | - | |||
| 2.55B | B | ||||||||
| 2.42B | - | - | - | - | - | ||||
| 2.34B | - | - | - | - | - | - | |||
| Average | 9.42B | BBB | |||||||
| Weighted average by Cap. | BBB |
Select your edition
All financial news and data tailored to specific country editions
















